Increased OPRM1 DNA methylation in lymphocytes of methadone (Neuropsychopharmacology (2008) DOI: 10.1038/npp.2008.108);Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts

Neuropsychopharmacology

Volumn 34, Issue 4, 2009, Pages 867-873

  Nielsen, David A ^a   Yuferov, Vadim ^a   Hamon, Sara ^a   Jackson, Colin ^a   Ho, Ann ^a   Ott, Jurg ^a,b   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Chinese Academy of Sciences and China National Center for Bioinformation   (China)

Author keywords

Addiction; CpG; Gene; Heroin; Methadone; Methylation

Indexed keywords

DNA; METHADONE; MU 1 OPIATE RECEPTOR; MU OPIATE RECEPTOR; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; DRUG THERAPY; FEMALE; HEROIN DEPENDENCE; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 59949091997     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.155     Document Type: Erratum

References (43)

1. Abdolmaleky HM, Cheng KH, Russo A, Smith CL, Faraone SV, Wilcox M et al (2005). Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 134B: 60-66.
2. Alikhani-Koopaei R, Fouladkou F, Frey FJ, Frey BM (2004). Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest 114: 1146-1157.
3. Andria ML, Simon EJ (1999). Localization of promoter elements in the human mu-opioid receptor gene and regulation by DNA methylation. Brain Res Mol Brain Res 70: 54-65.
4. Antequera F, Bird A (1993). Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci USA 90: 11995-11999.
5. Azaryan AV, Clock BJ, Rosenberger JG, Cox BM (1998). Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration. Can J Physiol Pharmacol 76: 278-283.
6. Bailey A, Gianotti R, Ho A, Kreek MJ (2005). Persistent upregulation of mu-opioid, but not adenosine, receptors in brains of long-term withdrawn escalating dose 'binge' cocaine-treated rats. Synapse 57: 160-166.
7. Bart G, Heilig M, LaForge KS, Pollak L, Leal SM, Ott J et al (2004). Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry 9: 547-549.
8. Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B 57: 289-300.
9. Black YD, Maclaren FR, Naydenov AV, Carlezon Jr WA, Baxter MG, Konradi C (2006). Altered attention and prefrontal cortex gene expression in rats after binge-like exposure to cocaine during adolescence. J Neurosci 26: 9656-9665.
10. Bleich S, Lenz B, Ziegenbein M, Beutler S, Frieling H, Kornhuber J et al (2006). Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. Alcohol Clin Exp Res 30: 587-591.
11. Bonsch D, Lenz B, Fiszer R, Frieling H, Kornhuber J, Bleich S (2006). Lowered DNA methyltransferase (DNMT-3b) mRNA expression is associated with genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm 113: 1299-1304.
12. Bonsch D, Lenz B, Kornhuber J, Bleich S (2005). DNA hypermethylation of the alpha synuclein promoter in patients with alcoholism. Neuroreport 16: 167-170.
13. Bonsch D, Lenz B, Reulbach U, Kornhuber J, Bleich S (2004). Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm 111: 1611-1616.
14. Chahrour M, Zoghbi HY (2007). The story of Rett syndrome: from clinic to neurobiology. Neuron 56: 422-437.
15. Douet V, Heller MB, Le Saux O (2007). DNA methylation and Sp1 binding determine the tissue-specific transcriptional activity of the mouse Abcc6 promoter. Biochem Biophys Res Commun 354: 66-71.
16. Gardiner-Garden M, Frommer M (1987). CpG islands in vertebrate genomes. J Mol Biol 196: 261-282.
17. Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino M et al (2005). Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry 57: 1573-1582.
18. Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A et al (2005). Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci USA 102: 9341-9346.
19. Halekoh U, Hojsgaard S (2006). The R package geepack for generalized estimating equations. J Stat Software 15: 1-11.
20. Iguchi-Ariga SM, Schaffner W (1989). CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev 3: 612-619.
21. Issa JP, Kantarjian H (2005). Azacitidine. Nat Rev Drug Discov Suppl: S6-S7.
22. Jaenisch R, Bird A (2003). Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33: 245-254.
23. Kreek MJ (2006). Endorphins, gene polymorphisms, stress responsivity, and special addictions: selected topics. In: Madras BK, Colvis CM, Pollock JD, Rutter JL, Shurtleff D, von Zastrow M (eds). Cell Biology of Addiction. Cold Spring Harbor Laboratory Press: Cold Spring Harbor. pp 63-92.
24. Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA (2005). Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev 57: 1-26.
25. Kumar A, Choi KH, Renthal W, Tsankova NM, Theobald DE, Truong HT et al (2005). Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48: 303-314.
26. Leri F, Zhou Y, Goddard B, Cummins E, Kreek MJ (2006). Effects of high-dose methadone maintenance on cocaine place conditioning, cocaine self-administration, and mu-opioid receptor mRNA expression in the rat brain. Neuropsychopharmacology 31: 1462-1474.
27. Lewin J, Schmitt AO, Adorjan P, Hildmann T, Piepenbrock C (2004). Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics 20: 3005-3012.
28. Marutha Ravindran CR, Ticku MK (2005). Role of CpG islands in the up-regulation of NMDA receptor NR2B gene expression following chronic ethanol treatment of cultured cortical neurons of mice. Neurochem Int 46: 313-327.
29. McCarthy L, Szabo I, Nitsche JF, Pintar JE, Rogers TJ (2001). Expression of functional mu-opioid receptors during T cell development. J Neuroimmunol 114: 173-180.
30. McLellan AT, Luborsky L, Woody GE, O'Brien CP (1980). An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 168: 26-33.
31. Michelotti GA, Brinkley DM, Morris DP, Smith MP, Louie RJ, Schwinn DA (2007). Epigenetic regulation of human alpha1d-adrenergic receptor gene expression: a role for DNA methylation in Sp1-dependent regulation. FASEB J 21: 1979-1993.
32. Miller CA, Sweatt JD (2007). Covalent modification of DNA regulates memory formation. Neuron 53: 857-869.
33. Peles E, Kreek MJ, Kellogg S, Adelson M (2006). High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. J Addict Dis 25: 43-50.
34. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276: 36734-36741.
35. Philibert RA, Gunter TD, Beach SR, Brody GH, Madan A (2008). MAOA methylation is associated with nicotine and alcohol dependence in women. Am J Med Genet B Neuropsychiatr Genet 147B: 565-570.
36. Renthal W, Maze I, Krishnan V, Covington III HE, Xiao G, Kumar A et al (2007). Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 56: 517-529.
37. Rettig RA, Yarmolinsky A (eds) (1995). Federal Regulation of Methadone Treatment. National Academy Press: Washington, DC.
38. Schug J, Overton GC (1977). TESS: Transcription Element Search Software on the WWW. Computational Biology and Informatics Laboratory, School of Medicine, University of Pennsylvania: Philadelphia.
39. Unterwald EM, Rubenfeld JM, Kreek MJ (1994). Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport 5: 1613-1616.
40. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR et al (2004). Epigenetic programming by maternal behavior. Nat Neurosci 7: 847-854.
41. Yuferov V, Zhou Y, Spangler R, Maggos CE, Ho A, Kreek MJ (1999). Acute 'binge' cocaine increases mu-opioid receptor mRNA levels in areas of the rat mesolimbic mesocortical dopamine system. Brain Res Bull 48: 109-112.
42. Zhang H, Darwanto A, Linkhart TA, Sowers LC, Zhang L (2007). Maternal cocaine administration causes an epigenetic modification of protein kinase Cepsilon gene expression in fetal rat heart. Mol Pharmacol 71: 1319-1328.
43. Zhou Y, Bendor J, Hofmann L, Randesi M, Ho A, Kreek MJ (2006). Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J Endocrinol 191: 137-145.